vs
Side-by-side financial comparison of Essent Group Ltd. (ESNT) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Essent Group Ltd. is the larger business by last-quarter revenue ($312.4M vs $164.7M, roughly 1.9× PTC THERAPEUTICS, INC.). Essent Group Ltd. runs the higher net margin — 49.6% vs -82.0%, a 131.6% gap on every dollar of revenue. On growth, Essent Group Ltd. posted the faster year-over-year revenue change (-0.8% vs -22.7%). Essent Group Ltd. produced more free cash flow last quarter ($848.7M vs $-36.6M). Over the past eight quarters, Essent Group Ltd.'s revenue compounded faster (2.3% CAGR vs -11.5%).
Essentra PLC is a supplier of plastic and fibre products. The company operates internationally from headquarters in Kidlington, Oxfordshire. It is listed on the London Stock Exchange.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
ESNT vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $312.4M | $164.7M |
| Net Profit | $155.0M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 59.1% | -43.3% |
| Net Margin | 49.6% | -82.0% |
| Revenue YoY | -0.8% | -22.7% |
| Net Profit YoY | -7.7% | -104.8% |
| EPS (diluted) | $1.61 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $312.4M | $164.7M | ||
| Q3 25 | $311.8M | $211.0M | ||
| Q2 25 | $319.1M | $178.9M | ||
| Q1 25 | $317.6M | $1.2B | ||
| Q4 24 | $315.0M | $213.2M | ||
| Q3 24 | $316.6M | $196.8M | ||
| Q2 24 | $312.9M | $186.7M | ||
| Q1 24 | $298.4M | $210.1M |
| Q4 25 | $155.0M | $-135.0M | ||
| Q3 25 | $164.2M | $15.9M | ||
| Q2 25 | $195.3M | $-64.8M | ||
| Q1 25 | $175.4M | $866.6M | ||
| Q4 24 | $167.9M | $-65.9M | ||
| Q3 24 | $176.2M | $-106.7M | ||
| Q2 24 | $203.6M | $-99.2M | ||
| Q1 24 | $181.7M | $-91.6M |
| Q4 25 | 59.1% | -43.3% | ||
| Q3 25 | 63.9% | 1.4% | ||
| Q2 25 | 72.4% | -19.5% | ||
| Q1 25 | 65.2% | 82.5% | ||
| Q4 24 | 61.9% | -76.2% | ||
| Q3 24 | 65.6% | -27.7% | ||
| Q2 24 | 76.4% | -21.5% | ||
| Q1 24 | 71.6% | -21.6% |
| Q4 25 | 49.6% | -82.0% | ||
| Q3 25 | 52.7% | 7.5% | ||
| Q2 25 | 61.2% | -36.3% | ||
| Q1 25 | 55.2% | 73.7% | ||
| Q4 24 | 53.3% | -30.9% | ||
| Q3 24 | 55.6% | -54.2% | ||
| Q2 24 | 65.1% | -53.1% | ||
| Q1 24 | 60.9% | -43.6% |
| Q4 25 | $1.61 | $-1.63 | ||
| Q3 25 | $1.67 | $0.20 | ||
| Q2 25 | $1.93 | $-0.83 | ||
| Q1 25 | $1.69 | $10.04 | ||
| Q4 24 | $1.59 | $-0.85 | ||
| Q3 24 | $1.65 | $-1.39 | ||
| Q2 24 | $1.91 | $-1.29 | ||
| Q1 24 | $1.70 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.8B | $-205.3M |
| Total Assets | $7.4B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $884.8M |
| Q4 25 | $5.8B | $-205.3M | ||
| Q3 25 | $5.7B | $-155.8M | ||
| Q2 25 | $5.7B | $-206.5M | ||
| Q1 25 | $5.7B | $-185.8M | ||
| Q4 24 | $5.6B | $-1.1B | ||
| Q3 24 | $5.6B | $-1.1B | ||
| Q2 24 | $5.4B | $-980.2M | ||
| Q1 24 | $5.2B | $-893.9M |
| Q4 25 | $7.4B | $2.9B | ||
| Q3 25 | $7.4B | $2.6B | ||
| Q2 25 | $7.2B | $2.6B | ||
| Q1 25 | $7.2B | $2.7B | ||
| Q4 24 | $7.1B | $1.7B | ||
| Q3 24 | $7.1B | $1.8B | ||
| Q2 24 | $6.7B | $1.9B | ||
| Q1 24 | $6.6B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $856.1M | $-34.3M |
| Free Cash FlowOCF − Capex | $848.7M | $-36.6M |
| FCF MarginFCF / Revenue | 271.7% | -22.3% |
| Capex IntensityCapex / Revenue | 2.4% | 1.4% |
| Cash ConversionOCF / Net Profit | 5.52× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.5B | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $856.1M | $-34.3M | ||
| Q3 25 | $215.9M | $-66.3M | ||
| Q2 25 | $189.5M | $-58.3M | ||
| Q1 25 | $221.6M | $870.1M | ||
| Q4 24 | $861.5M | $-30.0M | ||
| Q3 24 | $229.2M | $-77.0M | ||
| Q2 24 | $188.7M | $-71.5M | ||
| Q1 24 | $216.9M | $70.8M |
| Q4 25 | $848.7M | $-36.6M | ||
| Q3 25 | $210.6M | $-69.7M | ||
| Q2 25 | $188.8M | $-59.6M | ||
| Q1 25 | $221.3M | $868.4M | ||
| Q4 24 | $854.8M | $-33.8M | ||
| Q3 24 | $228.7M | $-77.5M | ||
| Q2 24 | $187.6M | $-78.8M | ||
| Q1 24 | $212.5M | $61.2M |
| Q4 25 | 271.7% | -22.3% | ||
| Q3 25 | 67.5% | -33.1% | ||
| Q2 25 | 59.2% | -33.3% | ||
| Q1 25 | 69.7% | 73.8% | ||
| Q4 24 | 271.3% | -15.8% | ||
| Q3 24 | 72.2% | -39.4% | ||
| Q2 24 | 60.0% | -42.2% | ||
| Q1 24 | 71.2% | 29.1% |
| Q4 25 | 2.4% | 1.4% | ||
| Q3 25 | 1.7% | 1.6% | ||
| Q2 25 | 0.2% | 0.7% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 2.1% | 1.8% | ||
| Q3 24 | 0.2% | 0.3% | ||
| Q2 24 | 0.3% | 4.0% | ||
| Q1 24 | 1.5% | 4.6% |
| Q4 25 | 5.52× | — | ||
| Q3 25 | 1.31× | -4.17× | ||
| Q2 25 | 0.97× | — | ||
| Q1 25 | 1.26× | 1.00× | ||
| Q4 24 | 5.13× | — | ||
| Q3 24 | 1.30× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 1.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESNT
| Mortgage Insurance Segment | $192.4M | 62% |
| Other | $120.0M | 38% |
PTCT
Segment breakdown not available.
